Effects of fluticasone furoate, vilanterol and umeclidinium bromide on moderate or severer asthmatic patients

Effects of fluticasone furoate, vilanterol and umeclidinium bromide on asthma - Fluticasone furoate, vilanterol and umeclidinium bromide on asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047506

Enrollment

100

Registered

2022-04-17

Start date

2021-02-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Moderate or severer asthma

Exclusion criteria

Exclusion criteria: Subjects who did not agree with the participation of the study.

Design outcomes

Primary

Measure	Time frame
Lung function tests and/or asthma control tests	—

Countries

Japan

Contacts

Public ContactAkira Umeda

International University of Health and Welfare Department of General Medicine, School of Medicine

aumeda@hf.catv.ne.jp0357074510

Outcome results